CompletedPhase 3

Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery

Serbia160 participantsStarted 2023-01-01

Plain-language summary

The study is a prospective, randomized, controlled trial to assess the effects of silymarin on the occurrence of postoperative atrial fibrillation after coronary artery bypass graft surgery.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * scheduled for elective CABG surgery using cardiopulmonary bypass * first cardiac surgery * left ventricular ejection fraction \> 35% * less than moderate mitral regurgitation Exclusion Criteria: * preoperative atrial fibrillation * previous history of interventionally treated arrhythmias * end-stage renal disease requiring hemodialysis * chronic inflammatory and neoplastic diseases

What they're measuring

Number of participants with postoperative atrial fibrillation

Timeframe: 4 days

Trial details

NCT IDNCT06114719

SponsorUniversity of Novi Sad

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Atrial Fibrillation New Onset trials